FDA inspection
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site): FDA inspection ending Nov 10, 2023
FDA inspection 1224895 · Voluntary Action Indicated (VAI) · Nanjing
Key facts
| Inspection ID | 1224895 |
|---|---|
| Firm | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) |
| FEI number | 3010625707 |
| Address | Nanjing High And New, No. 16 Xuefu Road; Technology Development Zone |
| City | Nanjing |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Nov 10, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data